Current status of polymeric gene delivery systems

Adv Drug Deliv Rev. 2006 Jul 7;58(4):467-86. doi: 10.1016/j.addr.2006.03.007. Epub 2006 Jun 15.

Abstract

Gene therapy provides great opportunities for treating diseases from genetic disorders, infections and cancer. To achieve successful gene therapy, development of proper gene delivery systems could be one of the most important factors. Several non-viral gene transfer methods have been developed to overcome the safety problems of their viral counterpart. Polymer-based non-viral gene carriers have been used due to their merits in safety including the avoidance of potential immunogenecity and toxicity, the possibility of repeated administration, and the ease of the establishment of good manufacturing practice (GMP). A wide range of polymeric vectors have been utilized to deliver therapeutic genes in vivo. The modification of polymeric vectors has also shown successful improvements in achieving target-specific delivery and in promoting intracellular gene transfer efficiency. Various systemic and cellular barriers, including serum proteins in blood stream, cell membrane, endosomal compartment and nuclear membrane, were successfully circumvented by designing polymer carriers having a smart molecular structure. This review explores the recent development of polymeric gene carriers and presents the future directions for the application of the polymer-based gene delivery systems in gene therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Gene Transfer Techniques*
  • Genetic Therapy / methods*
  • Genetic Therapy / trends
  • Genetic Vectors / chemistry
  • Genetic Vectors / genetics
  • Humans
  • Molecular Structure
  • Polyethyleneimine / analogs & derivatives
  • Polyethyleneimine / chemistry
  • Polylysine / analogs & derivatives
  • Polylysine / chemistry
  • Polymers / chemistry*

Substances

  • Polymers
  • Polylysine
  • Polyethyleneimine